Difference between revisions of "Basu-Roy U, et al. Oncotarget (2016) cited as Ref 388 in DOI: 10.1038/s41392-020-0110-5 (Q9651)"

@@ Property / First Author string @@
+Basu-Roy U
@@ Property / First Author string: Basu-Roy U / rank @@
+Normal rank
@@ Property / Publication Date @@
+Timestamp +2016-01-01T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 year
Before 0
After 0
-Timestamp
++2016-01-01T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+year
 Before
 After
@@ Property / Publication Date: 2016 / rank @@
+Normal rank
@@ Property / Published In Name String @@
+Oncotarget
@@ Property / Published In Name String: Oncotarget / rank @@
+Normal rank
@@ Property / Volume @@
@@ Property / Volume: 7 / rank @@
+Normal rank
@@ Property / title @@
+PPARgamma agonists promote differentiation of cancer stem cells by restraining YAP transcriptional activity. (English)
+Normal rank
@@ Property / Page(s) @@
+-60970
@@ Property / Page(s): 60954-60970 / rank @@
+Normal rank
@@ links / sliswiki / name / links / sliswiki / name @@
+Basu-Roy U, et al. Oncotarget (2016) cited as Ref 388 in DOI: 10.1038/s41392-020-0110-5

Latest revision as of 15:39, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

Language	Label	Description	Also known as
English	Basu-Roy U, et al. Oncotarget (2016) cited as Ref 388 in DOI: 10.1038/s41392-020-0110-5	Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8